Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma
Klinische Pädiatrie · 01.05.2024 · 236 (03) · 215
DOI: 10.1055/s-0044-1786625 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von S Thul und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma
Zitieren
APA
Thul, S., Reindl, L. M., Wendel, P., Burger, M. C., Steinbach, J. P., & Wels, W. S. (2024). Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma. Klinische Pädiatrie, 236(03), 215. https://doi.org/10.1055/s-0044-1786625
Vancouver
Thul S, Reindl LM, Wendel P, Burger MC, Steinbach JP, Wels WS. Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma. Klinische Pädiatrie. 2024;236(03):215. doi:10.1055/s-0044-1786625
BibTeX
@article{Thul2024,
author = {Thul, S and Reindl, L M and Wendel, P and Burger, M C and Steinbach, J P and Wels, W S},
title = {Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma},
journal = {Klinische Pädiatrie},
year = {2024},
volume = {236},
number = {03},
pages = {215},
doi = {10.1055/s-0044-1786625}
}
EUVIMED